Table 1.
Characteristics of the cohorts and analysis
| Characteristic | COVID‐19 pandemic, n = 64 | Non‐pandemic, n = 51 | P‐value |
|---|---|---|---|
| Demographics | |||
| Gender, female (%) | 33 (51.6) | 33 (64.7) | 0.110† |
| Age, mean (SD) (years) | 79.89 (11.20) | 79.71 (10.55) | 0.930‡ |
| Resides in residential care normally (%) | 7 (10.9) | 7 (13.7) | 0.534† |
| Reason for presentation | 0.803† | ||
| Acute physiological change (%) | 33 (51.6) | 28 (54.9) | |
| Concern over suspected diagnosis (%) | 17 (26.6) | 11 (21.6) | |
| Acute change in cognition (%) | 2 (3.1) | 1 (2.0) | |
| Acute change in physical function (%) | 9 (14.1) | 10 (19.6) | |
| Psychiatric (%) | 3 (4.7) | 1 (2.0) | |
| Subset | n = 24 | n = 24 | |
| Charlson Comorbidity Index (SD) | 6.15 (2.73) | 4.92 (2.08) | 0.0429*‡ |
| APACHE III score (SD) | 33.60 (12.50) | 28.46 (10.54) | 0.0652‡ |
*Significant (P < 0.05). †Fisher exact t‐test. ‡Student t‐test. SD, standard deviation.